The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Economic burden and patterns of care in patients with advanced hepatocellular carcinoma.
 
Abdalla Aly
Employment - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Pharmerit; Pharmerit; Pharmerit; Pharmerit
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Celldex; Celldex; Celldex; Celldex; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Pfizer; Pfizer; Pfizer; Pfizer; Pharmacyclics; Pharmacyclics; Pharmacyclics; Pharmacyclics; Takeda; Takeda; Takeda; Takeda
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Celldex; Celldex; Celldex; Celldex; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Pfizer; Pfizer; Pfizer; Pfizer; Pharmacyclics; Pharmacyclics; Pharmacyclics; Pharmacyclics; Takeda; Takeda; Takeda; Takeda
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
 
Elisabetta Malangone-Monaco
Employment - IBM; IBM; IBM; IBM
Consulting or Advisory Role - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Pharmacyclics/Janssen (Inst); Pharmacyclics/Janssen (Inst); Pharmacyclics/Janssen (Inst); Pharmacyclics/Janssen (Inst)
 
Virginia Noxon
Employment - IBM; IBM; IBM; IBM
Consulting or Advisory Role - Allergan (Inst); Allergan (Inst); Allergan (Inst); Allergan (Inst); Alnylam (Inst); Alnylam (Inst); Alnylam (Inst); Alnylam (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst)
 
Caroline Henriques
Employment - IBM; IBM; IBM; IBM
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Allergan (Inst); Allergan (Inst); Allergan (Inst); Allergan (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Janssen (Inst); Janssen (Inst); Janssen (Inst); Janssen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst)
 
Fernando Benavente
Employment - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
 
Amy K. Kim
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Eisai; Eisai; Eisai; Eisai
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca